Discover 772 paid clinical trials in British Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Acute High Fat Bulletproof Coffee vs Black Coffee on Metabolism, Inflammation and Cognitive Function in Healthy Adults
for
Leukocytosis, Triglycerides, Cognitive Function,
Location: Kelowna
Sponsor: University of British Columbia
Sex: All
Age: 18 - 55
Code: NCT04307979
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Halifax, Boston MA, New York NY, Montreal,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06615479
Phase3, Recruiting
Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)
for
Bladder Cancer, Bladder Cancer Recurrent, Neoplasm Recurrence,
Location: Kingston, Toronto, Vancouver
Sponsor: Verity Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT05037279
Phase3, Recruiting
Eliminating HCV Infection Among PWUD
for
Hepatitis C, Chronic, Drug Use
Location: Vancouver
Sponsor: Vancouver Infectious Diseases Centre
Sex: All
Age: 19+
Code: NCT05474781
Recruiting
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, New York NY, Toronto, Sarasota FL,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06752681
Phase1, Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant